Platelet-rich plasma: Renewed scientific understanding must guide appropriate use

Affiliations

¹ Department of Orthopaedics, The University of Edinburgh, Chancellors Building, Little France Crescent, Edinburgh, EH16 4SB, UK Iain.Murray@ed.ac.uk.
² Steadman Philippon Research Institute, Vail, Colorado, USA.

Editorial

I R Murray et al. Bone Joint Res. 2016 Mar.

. 2016 Mar;5(3):92-4.

doi: 10.1302/2046-3758.53.BJR-2016-0005.

¹ Department of Orthopaedics, The University of Edinburgh, Chancellors Building, Little France Crescent, Edinburgh, EH16 4SB, UK Iain.Murray@ed.ac.uk.
² Steadman Philippon Research Institute, Vail, Colorado, USA.

No abstract available

Conflict of interest statement

ICMJE conflict of interest: None declared.

1. Hall MP, Band PA, Meislin RJ, Jazrawi LM, Cardone DA. Platelet-rich plasma: current concepts and application in sports medicine. J Am Acad Orthop Surg 2009;17:602-608. - PubMed
1. Zaky SH, Ottonello A, Strada P, Cancedda R, Mastrogiacomo M. Platelet lysate favours in vitro expansion of human bone marrow stromal cells for bone and cartilage engineering. J Tissue Eng Regen Med 2008;2:472-481. - PubMed
1. Mishra A, Tummala P, King A, et al. Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Eng Part C Methods 2009;15:431-435. - PMC - PubMed
1. No authors listed. US Department of Health and Human Services: Human cells, tissues, and cellular and tissue-based products. 21 CFR Part 1271. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CF... (date last accessed 02 March 2016).[[bibmisc]]
1. Cox L. Tiger Admits to Platelet-Rich Plasma Therapy, What’s That? http://abcnews.go.com/Health/Technology/tiger-woods-admits-platelet-rich... (date last accessed 02 March 2016).[[bibmisc]]